Picture of Inozyme Pharma logo

INZY — Inozyme Pharma News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSucker Stock

Brief: Inozyme Pharma reports Q2 results

Aug 15 (Reuters) - Inozyme Pharma Inc  INZY.O :
    * INOZYME PHARMA REPORTS SECOND QUARTER 2022 FINANCIAL
RESULTS AND
PROVIDES BUSINESS UPDATES
    * INOZYME PHARMA - CASH, CASH EQUIVALENTS & INVESTMENTS AS
OF
QUARTER END, WITH FIRST TRANCHE OF DEBT FACILITY, FUNDS CASH
FLOW REQUIREMENTS INTO Q2 OF 2024
    * NET LOSS WAS $15.3 MILLION, OR $0.38 LOSS PER SHARE, FOR
THE
QUARTER ENDED JUNE 30, 2022
    * Q2 EARNINGS PER SHARE VIEW $-0.48 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX70snW0 
Further company coverage:  INZY.O

Recent news on Inozyme Pharma

See all news